Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel F Tyndale

Showing results (11-20 of 359) with videos related to

Pageof 36
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 31, 2012
Rat brain CYP2B-enzymatic activation of chlorpyrifos to the oxon mediates cholinergic neurotoxicityJibran Y Khokhar, Rachel F Tyndale
Journal of Psychopharmacology (Oxford, England)|June 21, 2006
Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatmentAnna M Lee, Rachel F Tyndale
Biochemical Pharmacology|August 25, 2017
Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic responseDouglas M McMillan, Rachel F Tyndale
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 30, 2015
Nicotine Increases Codeine Analgesia Through the Induction of Brain CYP2D and Central Activation of Codeine to MorphineDouglas M McMillan, Rachel F Tyndale
Advances in Pharmacology (San Diego, Calif.)|August 11, 2022
Cytochrome P450 enzymes and metabolism of drugs and neurotoxins within the mammalian brainMarlaina R Stocco, Rachel F Tyndale
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 26, 2010
Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effectsJibran Y Khokhar, Rachel F Tyndale
Trends in Molecular Medicine|January 9, 2018
Preparing the Way: Exploiting Genomic Medicine to Stop SmokingLaura J Bierut, Rachel F Tyndale
Clinical Pharmacology and Therapeutics|June 8, 2018
Opioids: The Painful Public Health RealityRachel F Tyndale, Edward M Sellers
Therapeutic Drug Monitoring|January 13, 2006
Genetic influences on smoking: a brief reviewNael Al Koudsi, Rachel F Tyndale
Biochimica Et Biophysica Acta|February 8, 2003
Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implicationsKerri A Schoedel, Rachel F Tyndale
Pageof 36

Showing results (11-20 of 359) with videos related to

Sort By:
Pageof 36
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 31, 2012
Rat brain CYP2B-enzymatic activation of chlorpyrifos to the oxon mediates cholinergic neurotoxicityJibran Y Khokhar, Rachel F Tyndale
Journal of Psychopharmacology (Oxford, England)|June 21, 2006
Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatmentAnna M Lee, Rachel F Tyndale
Biochemical Pharmacology|August 25, 2017
Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic responseDouglas M McMillan, Rachel F Tyndale
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 30, 2015
Nicotine Increases Codeine Analgesia Through the Induction of Brain CYP2D and Central Activation of Codeine to MorphineDouglas M McMillan, Rachel F Tyndale
Advances in Pharmacology (San Diego, Calif.)|August 11, 2022
Cytochrome P450 enzymes and metabolism of drugs and neurotoxins within the mammalian brainMarlaina R Stocco, Rachel F Tyndale
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 26, 2010
Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effectsJibran Y Khokhar, Rachel F Tyndale
Trends in Molecular Medicine|January 9, 2018
Preparing the Way: Exploiting Genomic Medicine to Stop SmokingLaura J Bierut, Rachel F Tyndale
Clinical Pharmacology and Therapeutics|June 8, 2018
Opioids: The Painful Public Health RealityRachel F Tyndale, Edward M Sellers
Therapeutic Drug Monitoring|January 13, 2006
Genetic influences on smoking: a brief reviewNael Al Koudsi, Rachel F Tyndale
Biochimica Et Biophysica Acta|February 8, 2003
Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implicationsKerri A Schoedel, Rachel F Tyndale
Pageof 36